Nuo Therapeutics, Inc. (AURX)

R&D Expense Growth

0.00%

Quarterly · Period ending:

AURX logo

AURX R&D Expense Growth

Latest reported0.00%
AURX Quarterly R&D Growth (QoQ) (0.00% → 0.00%)
High-resolution chart · PNG

AURX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-100%
-96.7909%
-10.8227%
14.2172%
-13.491%
-31.8283%
-45.7178%
-19.3507%
6.8352%
-3.2341%
-22.515%
-14.6637%
44.7024%
-19.8921%
7.6208%
-46.6547%
36.5215%
-13.8299%
-18.6042%
866.6632%
-88.0576%
-33.5616%
0.4146%
27.4364%
-18.9209%
-24.6748%
35.896%
-3.2344%
-7.3779%
-7.8083%
205.411%
4,584.2871%
-296.1112%
-90.3508%
-29.7584%
-42.0649%
13.3755%
-41.6497%
142.5253%
33.8376%
25,530.8511%
-99.8119%
26.1766%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.